Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

DCK Antikörper

KO Validated DCK Reaktivität: Human WB, IHC, IF, IP, IHC (p), ICC Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN2855484
  • Target Alle DCK Antikörper anzeigen
    DCK (Deoxycytidine Kinase (DCK))
    Reaktivität
    • 49
    • 27
    • 14
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    Human
    Wirt
    • 38
    • 11
    • 3
    Kaninchen
    Klonalität
    • 43
    • 9
    Polyklonal
    Konjugat
    • 34
    • 4
    • 4
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser DCK Antikörper ist unkonjugiert
    Applikation
    • 36
    • 21
    • 20
    • 19
    • 16
    • 10
    • 8
    • 4
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB), Immunohistochemistry (IHC), Immunofluorescence (IF), Immunoprecipitation (IP), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunocytochemistry (ICC)
    Kreuzreaktivität
    Human, Maus, Ratte
    Produktmerkmale
    Rabbit Polyclonal antibody to DCK (deoxycytidine kinase)
    DCK antibody
    Aufreinigung
    Purified by antigen-affinity chromatography.
    Güteklasse
    KO Validated
    Immunogen
    Recombinant protein encompassing a sequence within the center region of human DCK. The exact sequence is proprietary.
    Isotyp
    IgG
    Top Product
    Discover our top product DCK Primärantikörper
  • Applikationshinweise
    WB: 1:1000-1:20000. ICC/IF: 1:100-1:1000. IHC-P: 1:100-1:1000. IP: 1:100-1:500. Optimal dilutions/concentrations should be determined by the researcher. Not tested in other applications.
    Kommentare

    Positive Control: PC-12 , Rat2 , A549 , H1299 , 293T , DCK-transfected 293T

    Validation: KO/KD, Overexpression

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Konzentration
    1.41 mg/mL
    Buffer
    1XPBS pH 7, 20 % Glycerol, 0.025 % ProClin 300
    Konservierungsmittel
    ProClin
    Vorsichtsmaßnahmen
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    4 °C,-20 °C
    Informationen zur Lagerung
    Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4°C. For long-term storage, aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
  • Target
    DCK (Deoxycytidine Kinase (DCK))
    Andere Bezeichnung
    deoxycytidine kinase (DCK Produkte)
    Synonyme
    dck antikoerper, DCK antikoerper, wu:fc15f06 antikoerper, zgc:101771 antikoerper, dck1 antikoerper, deoxycytidine kinase antikoerper, deoxycytidine kinase, gene 2 L homeolog antikoerper, deoxycytidine kinase, gene 2 antikoerper, Deoxycytidine kinase antikoerper, deoxycytidine kinase, gene 1 L homeolog antikoerper, DCK antikoerper, dck antikoerper, dck.2.L antikoerper, dck.2 antikoerper, Dck antikoerper, FPV059 antikoerper, FPV151 antikoerper, dck.1.L antikoerper
    Hintergrund
    Deoxycytidine kinase (DCK) is required for the phosphorylation of several deoxyribonucleosides and their nucleoside analogs. Deficiency of DCK is associated with resistance to antiviral and anticancer chemotherapeutic agents. Conversely, increased deoxycytidine kinase activity is associated with increased activation of these compounds to cytotoxic nucleoside triphosphate derivatives. DCK is clinically important because of its relationship to drug resistance and sensitivity.

    Cellular Localization: Nucleus
    Molekulargewicht
    31 kDa
    Gen-ID
    1633
    UniProt
    P27707
Sie sind hier:
Kundenservice